Acne: Isotretinoin Monitoring
On this page
Direct answer
Treat every isotretinoin prescription as a controlled experiment with a teratogenic core. Standard dosing runs 0.5-1 mg/kg/day until a cumulative total of 120-150 mg/kg, the threshold that best prevents relapse, though Indian practice also runs low-dose regimens of 10-20 mg daily for longer durations with fewer mucocutaneous effects. Baseline fasting lipids and liver enzymes are checked, repeated at one to two months and thereafter only if abnormal or risk-laden, since routine lifelong monitoring in healthy young adults is not evidence-supported. Two rules admit no negotiation: reliable contraception from one month before through one month after therapy, and never co-prescribing tetracyclines, because both drugs raise intracranial pressure.
What you must remember
- Dose math: 0.5-1 mg/kg/day; start low in severe or maculopapular-flare-prone acne; cumulative target 120-150 mg/kg predicts durable clearance.
- Cheilitis is the watermark: nearly universal dry lips confirm adherence — a hidden practical pearl; xerosis, photosensitivity, epistaxis and dermatitis of dry skin follow.
- Laboratory schedule and the pancreatitis number: fasting triglycerides, cholesterol and liver enzymes at baseline, rechecked at 1-2 months; continue only if values rise, risk factors exist (diabetes, obesity, family dyslipidaemia, alcohol) or the dose is high — triglycerides climbing towards 800-1000 mg/dL warrant stopping to avert pancreatitis, and milder rises settle with dose reduction.
- Teratogenesis protocol: two complementary contraception methods, started one month before, continued one month after cessation per current labelling; a negative pregnancy test precedes the first tablet in women of childbearing age.
- Never with tetracyclines: the combination of isotretinoin and doxycycline or minocycline risks pseudotumour cerebri — a recurring exam favourite.
- Musculoskeletal cautions: myalgia is common and creatine kinase rises with heavy gym training; cap intense exercise, and expect minor axial hyperostosis only with prolonged high-dose courses.
- Procedure gap: no waxing, dermabrasion, medium or deep peels during therapy and for six months after, because impaired wound healing promotes scarring; blood donation is deferred one month.
- Mood question: counsel and document; causality with depression remains unproven, but the consultation is mandatory.
A monitoring walkthrough, month by month
A 21-year-old woman, 52 kg, has nodulocystic acne scarring her cheeks. Pregnancy test negative, contraception discussed, two methods agreed, fasting lipids and liver profile normal. Isotretinoin 20 mg daily (about 0.4 mg/kg) starts low because nodulocystic disease flares on induction; she is told that acne may worsen in weeks two to four. Month 1 review: cheilitis present — adherence confirmed — mild dryness managed with lip balm and a bland emollient; labs repeat at month 2: triglycerides 210 mg/dL, ALT just above the upper limit, both acceptable. Dose rises to 30 mg; her cumulative ledger runs in the folder. Month 4: skin nearly clear, mood stable, no myalgia. Month 6: cumulative dose approaches 110 mg/kg, and the plan closes at roughly 120 mg/kg around month 7, with a final instruction set — contraception one more month, no facial procedures for six, and a clear statement that relapse, if it comes, usually does so within two years and responds to a second course.
Where students slip
The prescription that combines isotretinoin with doxycycline for "severe acne, dual coverage" is the classic trap — the correct partner answer is that no antibiotic needs adding and the tetracycline class is specifically dangerous here. The second slip is duration logic: stopping at cosmetic clearance instead of the cumulative dose of 120-150 mg/kg, then wondering why relapse rates climb. Third, monitoring ritualism: demanding monthly bloods for a healthy 19-year-old on 20 mg misreads the evidence as much as never checking at all — the middle path of baseline plus early recheck, then risk-driven testing, is the defensible position in a viva. Finally, the contraception window: candidates quote outdated durations; current labelling requires coverage one month before to one month after, and saying so precisely earns the mark.
Frequently asked questions
What is the standard cumulative target dose of isotretinoin?
120-150 mg/kg total across the course, the range associated with the lowest relapse rates after cessation.
Which laboratory tests are monitored on isotretinoin?
Fasting serum triglycerides and cholesterol plus liver enzymes at baseline and 1-2 months, then only if abnormal or if risk factors exist.
Why must tetracyclines never accompany isotretinoin?
Both drug classes raise intracranial pressure, and combined use risks pseudotumour cerebri with papilloedema.
How long after stopping isotretinoin must pregnancy be avoided?
One month, per current labelling, with reliable contraception practised from one month before initiation until that point.
Which cosmetic procedures are deferred during and after therapy?
Waxing, dermabrasion and medium-to-deep chemical peels for six months after the last dose, because impaired wound healing promotes scarring.